Patent · US Active

Iridinesulfonamide compound and use method thereof

US11203586B2 · kind B2 · utility

0Cited by

0References

16Claims

0Family size

Assignees

Inventors

Li Zhu · Shanghai, CN
Yanqing Yang · Beijing, CN
Liguang Dai · Beijing, CN
Xiaowei Duan · Beijing, CN
Zhao Yang · Beijing, CN
Hui Zhang · Jinan, CN
Yuandong Hu · Beijing, CN
Yong Peng · Beijing, CN
Yongxin Han · Kirkland, CA
Rui Zhao · Beijing, CN
Xin Tian · 安丰镇, CN
Shanchun Wang · 安丰镇, CN

Key dates

Filing date	Mar 22, 2017
Grant date	Dec 21, 2021
Priority date	—
Expiry date	Oct 1, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/55
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

An iridinesulfonamide compound having isocitrate dehydrogenase 1 (IDH1) inhibitory activity, pharmaceutically acceptable salts, solvates or hydrates thereof, a pharmaceutical composition, as well as use of the compound or the pharmaceutically acceptable salts, solvates or hydrates thereof, and the pharmaceutical composition thereof in treating IDH1 mutation induced cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.